Related Experiment Videos

[Meticillin resistant Staphylococcus aureus in Norway]

Petter Elstrøm1, Preben Aavitsland

  • 1Avdeling for infeksjonsovervåking Nasjonalt folkehelseinstitutt Postboks 4404 Nydalen 0403 Oslo. petter.elstrom@fhi.no

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) infections are increasing in Nordic countries, necessitating updated treatment guidelines. A "search and destroy" strategy is recommended, focusing on high-risk individuals and healthcare settings to curb MRSA spread.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Context:

  • Staphylococcus aureus, particularly Methicillin-resistant Staphylococcus aureus (MRSA), poses a significant threat in healthcare settings and among vulnerable populations.
  • MRSA infections are associated with increased morbidity and mortality compared to sensitive strains.
  • The rising incidence of MRSA necessitates a re-evaluation of current treatment and control strategies.

Purpose:

  • To review the current literature and national guidelines regarding MRSA prevention and control.
  • To inform the development of updated guidelines for empirical treatment of staphylococcal infections.
  • To analyze the incidence and strategic approaches to MRSA in Nordic countries and the Netherlands.

Summary:

  • The incidence of MRSA, while historically low in Nordic countries, is on the rise.
  • A "search and destroy" strategy is employed in the Netherlands and Nordic countries, with variations in implementation.
  • Proposed Norwegian guidelines suggest a "search and destroy" approach within hospitals, targeting high-risk individuals outside healthcare to prevent transmission.

Impact:

  • Updated treatment guidelines may increase healthcare costs but are crucial for managing MRSA.
  • Accelerated evolution of bacterial resistance is a concern.
  • Effective MRSA control strategies are vital to mitigate severe infections and improve patient outcomes.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...